This study examines the role of ( 18 ) F-labeled fluorodeoxyglucose positron emission tomography ( FDG-PET ) in the implementation of involved-node radiation therapy ( INRT ) in patients treated for clinical stages ( CS ) I/II supradiaphragmatic Hodgkin lymphoma ( HL ) .